Epithelial and mesenchymal CTC detection in triple negative breast cancer patients using ANGLE's Parsortix®system

被引：0
|
作者：
Mezni, Amina [1 ]
Hardy, Matthew [1 ]
Ciccioli, Mariacristina [1 ]
Pailhes-Jimenez, Anne-Sophie [1 ]
机构：
[1] ANGLE Plc, Guildford, Surrey, England
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
969
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intratumoral bidirectional transitions between epithelial and mesenchymal ce lls in triple-negative breast cancer
    Yamamoto, Mizuki
    Inoue, Jun-ichiro
    CANCER SCIENCE, 2018, 109 : 1217 - 1217
  • [32] Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer
    Al Moustafa, Ala-Eddin
    CELL ADHESION & MIGRATION, 2013, 7 (05) : 424 - 425
  • [33] Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition
    Elizabeth Garcia
    Ismat Luna
    Kaya L. Persad
    Kate Agopsowicz
    David A. Jay
    Frederick G. West
    Mary M. Hitt
    Sujata Persad
    Scientific Reports, 11
  • [34] Role of beta-catenin in epithelial-to-mesenchymal transition pathway in triple negative breast cancer
    Ahmed, S. S.
    Iqbal, J.
    Thike, A. A.
    HISTOPATHOLOGY, 2012, 61 : 11 - 11
  • [35] Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto, Mizuki
    Inoue, Jun-ichiro
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 64 - 64
  • [36] DNA hypermethylation plays an important role in the epithelial-mesenchymal transition in triple negative breast cancer
    Santucci-Pereira, Julia
    Su, Yanrong
    Russo, Jose
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto, Mizuki
    Inoue, Jun-ichiro
    CANCER SCIENCE, 2018, 109 : 651 - 651
  • [38] Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
    Waryah, Charlene
    Cursons, Joseph
    Foroutan, Momeneh
    Pflueger, Christian
    Wang, Edina
    Molania, Ramyar
    Sorolla, Anabel
    Wallis, Christopher
    Moses, Colette
    Glas, Irina
    Magalhaes, Leandro
    Thompson, Erik W.
    Fearnley, Liam G.
    Chaffer, Christine L.
    Davis, Melissa
    Papenfuss, Anthony T.
    Redfern, Andrew
    Lister, Ryan
    Esteller, Manel
    Blancafort, Pilar
    ADVANCED SCIENCE, 2023, 10 (22)
  • [39] 4-marker positive selection system for improved CTC analysis in metastatic triple negative breast cancer
    Hancock, Bradley
    Chang, Chun-Li
    Zhong, Yuan
    Chen, Yu-Hsiang
    Solzak, Jeffrey
    Bales, Casey
    Nelson, Emily
    Paul, Robin
    Savran, Cagri
    Radovich, Milan
    CANCER RESEARCH, 2019, 79 (13)
  • [40] mesenchymal stem cell-derived exosomes promote epithelial-to-mesenchymal transition in triple negative breast cancer cells
    Jurj, Ancuta
    Soritau, Olga
    Raduly, Lajos
    Moldovan, Cristian
    Braicu, Cornelia
    Berindan-Neagoe, Ioana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 432 - 432
12345